Are we talking about a suspension of the trading (which wouldn't be such a big problem) or a delisting of the company? There is a big diffference. As I mentioned in my last post (#14808) but no one seemed to notice, the YE2012 will be due in 2 weeks (04/10) and Q1 2013 is due May 15. We are more than one year late in filings. Indeed, correct me if I'm wrong, even though YE2011 would be audited and filed next Monday, we wouldn't be current at all, anyway. We would be still late for the 3 quarters of 2012 and YE2012 as well as Q1 2013 will become due before we can even think about being current.
By the way, Alias doesn't have to be an outsider to know that Financials would have not shown anything good 3 or 9 months ago; everyone knows that this company has almost no revenue and a lot of expenses, but don't think that Cynthia postponed anything voluntarily in order to show better results First, she badly needs this company to be current in order to finance it with all her institutions she is supposed to work with and, second, even the last results wouldn't be better anyway. The contract with Oncobiologics doens't appear anywhere in these figures, it's a revenue projection only (for now, when they proceed, it would be an investment only) and it's not a 400 000$ difference in wages at BPD that will make this company look better. We are looking at a company that can have hundreds of millions of dollars of revenu in the future, do you really think that a 300-400K will make a difference. BPD means nothing in this company. The best we can hope for is that they increase their revenu to 1 million with an EBITDA over 0, who cares?
The biosimilars contracts like Oncobiologics will get us rich, not BPD ...if we stay listed and become current before anything else.
She needs to finance it to pay the peole so they can deliver the financials. I'm pretty sure that's the reason why nothing happens.
